drugset / Trial / NCT02687763
Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant
NaSingle-groupOpen-labelOther
Summary
A prospective, multisite study to evaluate the Impact of Measles, Mumps, Rubella and Varicella ProQuad® vaccination in pediatric patients 6-24 months of age who are being considered and/or evaluated for any solid organ transplant (heart, liver or kidney)
Timeline
- Start
- 2015-12
- Primary completion
- 2016-11-03
- Completion
- 2016-11-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ProQuad | Vaccine | 0.5 ml | Intramuscular |